bisindolylmaleimide i has been researched along with Cancer of Endometrium in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, HM | 1 |
| Schally, AV | 1 |
| Cheng, JC | 1 |
| Zarandi, M | 1 |
| Varga, J | 1 |
| Leung, PC | 1 |
1 other study available for bisindolylmaleimide i and Cancer of Endometrium
| Article | Year |
|---|---|
Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCĪ“-mediated activation of p53/p21.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Endometrial Neopl | 2010 |